Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
01 3Cohance Lifesciences
02 2Altius Healthcare
03 2Apotex Inc
04 2Ascent Innovative Medicines
05 1Aspire Lifesciences Pvt Ltd
06 2ENDO OPERATIONS
07 2Kolmar Korea Co., Ltd.
08 2Laboratorio Eczane Pharma
09 2Orchid Pharma
10 4Pelcoat Formulations
11 2Smilax Laboratories Limited
12 2TWi Pharmaceuticals
13 11Takeda Pharmaceutical
14 2Viatris
15 4World Medicine
01 4CAPSULE
02 6CAPSULE (DELAYED RELEASE)
03 8CAPSULE, DELAYED RELEASE;ORAL
04 6Caps
05 4Capsule
06 2DR CAPSULE
07 2DR Capsule
08 1Delayed Release Pellet
09 4Enteric Coated Pellets
10 3Pellets
11 1TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL
12 2Tablet
01 1DISCN
02 2Generic
03 2Generic EU CTD
04 6Prescription
05 8RX
06 24Blank
01 2APO-DEXLANSOPRAZOLE
02 4DEXILANT
03 1DEXILANT SOLUTAB
04 8DEXLANSOPRAZOLE
05 2Decpranzole Tablet
06 6Dexilant
07 2Dexprane
08 2EKSDELAN
09 16Blank
01 2Argentina
02 6Canada
03 14India
04 2South Korea
05 6Switzerland
06 4Turkey
07 9USA
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 30MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 60MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Delayed Release Pellet
Dosage Strength : 22.5%
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : DR Capsule
Dosage Strength : 30MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : DR Capsule
Dosage Strength : 60MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Pellets
Dosage Strength : 17%W/W
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : South Korea
Brand Name : Decpranzole Tablet
Dosage Form : Tablet
Dosage Strength : 30MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : South Korea
Regulatory Info :
Registration Country : South Korea
Brand Name : Decpranzole Tablet
Dosage Form : Tablet
Dosage Strength : 60MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : South Korea
Regulatory Info :
Registration Country : Argentina
Brand Name : Dexprane
Dosage Form : Capsule
Dosage Strength : 30MG
Packaging : 30 Caps
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Argentina
Regulatory Info :
Registration Country : Argentina
Brand Name : Dexprane
Dosage Form : Capsule
Dosage Strength : 60MG
Packaging : 30 Caps
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Argentina
Regulatory Info : Generic EU CTD
Registration Country : India
Brand Name :
Dosage Form : DR CAPSULE
Dosage Strength : 30MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic EU CTD
Registration Country : India
Regulatory Info : Generic EU CTD
Registration Country : India
Brand Name :
Dosage Form : DR CAPSULE
Dosage Strength : 60MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic EU CTD
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Enteric Coated Pellets
Dosage Strength : 8.5%/W/W
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Enteric Coated Pellets
Dosage Strength : 15%/W/W
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Enteric Coated Pellets
Dosage Strength : 17%/W/W
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Enteric Coated Pellets
Dosage Strength : 20%/W/W
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : RX
Registration Country : USA
Brand Name : DEXILANT
Dosage Form : CAPSULE, DELAYED RELEASE;ORAL
Dosage Strength : 30MG
Packaging :
Approval Date : 2009-01-30
Application Number : 22287
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DEXILANT
Dosage Form : CAPSULE, DELAYED RELEASE;ORAL
Dosage Strength : 60MG
Packaging :
Approval Date : 2009-01-30
Application Number : 22287
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DEXILANT SOLUTAB
Dosage Form : TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL
Dosage Strength : 30MG
Packaging :
Approval Date : 2016-01-26
Application Number : 208056
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : Switzerland
Brand Name : Dexilant
Dosage Form : Caps
Dosage Strength : 30mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info : RX
Registration Country : USA
Brand Name : DEXLANSOPRAZOLE
Dosage Form : CAPSULE, DELAYED RELEASE;ORAL
Dosage Strength : 30MG
Packaging :
Approval Date : 2022-09-16
Application Number : 202666
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DEXLANSOPRAZOLE
Dosage Form : CAPSULE, DELAYED RELEASE;ORAL
Dosage Strength : 60MG
Packaging :
Approval Date : 2022-09-16
Application Number : 202666
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DEXLANSOPRAZOLE
Dosage Form : CAPSULE, DELAYED RELEASE;ORAL
Dosage Strength : 30MG
Packaging :
Approval Date : 2024-01-19
Application Number : 205205
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DEXLANSOPRAZOLE
Dosage Form : CAPSULE, DELAYED RELEASE;ORAL
Dosage Strength : 60MG
Packaging :
Approval Date : 2024-01-19
Application Number : 205205
Regulatory Info : RX
Registration Country : USA
Regulatory Info : Generic
Registration Country : Turkey
Brand Name :
Dosage Form : CAPSULE
Dosage Strength : 30MG
Packaging : 14 Or 28 Capsules
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : Turkey
Regulatory Info : Generic
Registration Country : Turkey
Brand Name :
Dosage Form : CAPSULE
Dosage Strength : 60MG
Packaging : 14 Or 28 Capsules
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : Turkey
Regulatory Info :
Registration Country : Turkey
Brand Name : EKSDELAN
Dosage Form : CAPSULE
Dosage Strength : 30MG
Packaging : 14 OR 28 CAPSULES
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Turkey
Regulatory Info :
Registration Country : Turkey
Brand Name : EKSDELAN
Dosage Form : CAPSULE
Dosage Strength : 60MG
Packaging : 14 OR 28 CAPSULES
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Turkey
Regulatory Info : RX
Registration Country : USA
Brand Name : DEXLANSOPRAZOLE
Dosage Form : CAPSULE, DELAYED RELEASE;ORAL
Dosage Strength : 60MG
Packaging :
Approval Date : 2017-04-19
Application Number : 202294
Regulatory Info : RX
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info : RX
Registration Country : USA
Brand Name : DEXLANSOPRAZOLE
Dosage Form : CAPSULE, DELAYED RELEASE;ORAL
Dosage Strength : 30MG
Packaging :
Approval Date : 2022-06-16
Application Number : 202294
Regulatory Info : RX
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
LOOKING FOR A SUPPLIER?
